HISTIOCYTIC NEOPLASM
Clinical trials for HISTIOCYTIC NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new HISTIOCYTIC NEOPLASM trials appear
Sign up with your email to follow new studies for HISTIOCYTIC NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Last-Resort drug access opens for rare tumor patients
Disease control AVAILABLEThis program provides mirdametinib to individual patients with severe, life-threatening conditions like NF1-related tumors or MAP-K pathway diseases who have no other treatment options and cannot join a clinical trial. Each case requires approval from the company, ethics board, a…
Matched conditions: HISTIOCYTIC NEOPLASM
Sponsor: SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New pill targets hard-to-treat cancers with KRAS and BRAF mutations
Disease control Recruiting nowThis early-phase study tests an oral drug called S241656 in adults with advanced cancers that have certain gene changes (KRAS, BRAF, and others). The drug is given alone or with other cancer treatments. The goal is to find safe doses and see if the drug shrinks tumors. About 554 …
Matched conditions: HISTIOCYTIC NEOPLASM
Phase: PHASE1, PHASE2 • Sponsor: Institut de Recherches Internationales Servier • Aim: Disease control
Last updated May 12, 2026 13:40 UTC